默克公司近日宣布,美国FDA已批准Emend(a prepitant、阿瑞吡坦)与其他止 吐药联用于刚开始或已多次采用致吐性抗癌药化疗的患者,防止抗癌药引起的恶心呕 吐,如采用高致吐性的铂类抗癌药物。 试验结果显示,使用常规疗法的患者只有51%的人出现了完全应答,而使用 Emend 治疗的患者当中,出现完全应答的人更多。此外,两者相比,Emend在防止患者日常生 活当中出现恶心呕吐的效果更好。 Emend仅用于预防化疗可能出现的呕吐,而不作为开始呕吐后的止吐用药。 处方信息摘要 适应症 在与其他止吐剂的组合: 没有研究的恶心和呕吐的既定治疗。 校订,给出了三天,作为引起的恶心和呕吐(CINV之)疗程的化疗,其中包括类固醇和5 - HT3受体拮抗剂的一部分。 推荐的校订口服剂量为术后恶心和呕吐(PONV)的标志是40前的3小时内麻醉诱导毫克。 禁忌 药物相互作用 How to take EMENDEMEND, in combination with other medicines, helps prevent CINV. EMEND is given on the first day of chemotherapy and for 2 days afterward. Take EMEND exactly as prescribed. Your doctor may prescribe EMEND, along with other medicines, in
EMEND (APREPITANT) Emend Information Emend is a popular medicine that is also generically known under the name of Aprepitant. This drug is known to block the actions of some harmful chemicals that are found in the patient’s organism and that usually trigger vomiting and nausea. Therefore, this medicine is widely used to prevent vomiting and nausea (these might be caused by cancer chemotherapy or surgery). This drug is unable to treat vomiting and nausea (it can only prevent them). Emend Indications Emend is a medicine that is usually prescribed to patients who are suffering from severe nausea and vomiting. However, this medicine might also be used to treat or to prevent some other medical disorders that have not been listed here. Emend Warnings Before you start taking Aprepitant, you must alert your doctor if you are suffering from liver disease. In this case, you may not be allowed to start taking this drug, or you might have to take in a lower dose of Emend. This drug is known to sometimes decrease the effectiveness of several birth-control pills, thus enabling the patient to become pregnant. During your treatment with this drug, you should use a non-hormonal birth control method (for example a diaphragm, spermicides or condoms). Emend Intake Guidelines You should take this drug according to your personal doctor’s instructions. If you fail to understand some of them, you should ask a pharmacist, a doctor or a nurse for further explanations. You should carefully read the information in the medicine’s label for further instructions and advice. You must accompany each dose of Emend with a glass of water (8 ounces of liquid). The first dose of Aprepitant should be taken 3 hours before a major surgery or 1 hour before a chemotherapy treatment. Sometimes this drug is combined with some other medicines, in order to increase its effectiveness. Emend should be kept out of the children’s reach, away from heat, direct sunlight and moisture. Emend Dosage You should ask your doctor to tell you the dose of Emend that should work best for you. This drug’s dosage is known to vary from one case to another, because it depends on a variety of factors such as age, general health condition, etc. You must not make any adjustments to the dose that you have been prescribed without asking your physician first. Emend Overdose If you suspect that you are suffering from overdose with Emend, you are in need of medical care. Overdose symptoms with this medicine usually include headache and drowsiness. Emend Missed Dose If you happen to miss one of your Emend doses, take it as soon as you remember. If it is time for another Aprepitant dose, you should skip the one that you have missed and proceed with your regular treatment. Do not take a double dose of this medicine without your physician’s approval. Emend side effects You should seek emergency medical help if you are experiencing any of these symptoms of an allergic reaction: difficulty breathing; hives; swelling of your face, tongue, lips, or throat. Alert your physician if you have any of these severe side effects: slow heart rate; tiredness or weakness; Emend Drug Reactions Before you start taking Emend, you should tell your personal doctor if you are also taking any of the following medicines: certain cancer drugs such as irinotecan (Camptosar), etoposide (VePesid), imatinib (Gleevec), ifosfamide (Ifex), vinblastine (Velban), vinorelbine (Navelbine), or vincristine (Oncovin, Vincasar); |